JP2013508411A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508411A5
JP2013508411A5 JP2012535426A JP2012535426A JP2013508411A5 JP 2013508411 A5 JP2013508411 A5 JP 2013508411A5 JP 2012535426 A JP2012535426 A JP 2012535426A JP 2012535426 A JP2012535426 A JP 2012535426A JP 2013508411 A5 JP2013508411 A5 JP 2013508411A5
Authority
JP
Japan
Prior art keywords
diet
patient
food
therapeutic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012535426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/053821 external-priority patent/WO2011050302A2/en
Publication of JP2013508411A publication Critical patent/JP2013508411A/ja
Publication of JP2013508411A5 publication Critical patent/JP2013508411A5/ja
Pending legal-status Critical Current

Links

JP2012535426A 2009-10-22 2010-10-22 癌治療の効果を高め、その副作用を軽減する方法および栄養製剤 Pending JP2013508411A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25415409P 2009-10-22 2009-10-22
US61/254,154 2009-10-22
PCT/US2010/053821 WO2011050302A2 (en) 2009-10-22 2010-10-22 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment

Publications (2)

Publication Number Publication Date
JP2013508411A JP2013508411A (ja) 2013-03-07
JP2013508411A5 true JP2013508411A5 (enExample) 2013-11-21

Family

ID=43900993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535426A Pending JP2013508411A (ja) 2009-10-22 2010-10-22 癌治療の効果を高め、その副作用を軽減する方法および栄養製剤

Country Status (13)

Country Link
US (2) US20110118528A1 (enExample)
EP (1) EP2490684B1 (enExample)
JP (1) JP2013508411A (enExample)
CN (1) CN102753162A (enExample)
AU (2) AU2010310515B2 (enExample)
BR (1) BR112012009423A2 (enExample)
CA (1) CA2779282C (enExample)
DK (1) DK2490684T3 (enExample)
ES (1) ES2659353T3 (enExample)
PL (1) PL2490684T3 (enExample)
PT (1) PT2490684T (enExample)
RU (1) RU2549954C2 (enExample)
WO (1) WO2011050302A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014066426A1 (en) 2012-10-22 2014-05-01 University Of Southern California Methods and formulations promoting tissue/organ regeneration, longevity and healthspan
EP3510875B1 (en) * 2013-02-12 2020-06-10 University of Southern California Diet composition for use in a therapeutic method of lowering blood glucose and/or igf-1 levels
CN105431055A (zh) 2013-07-01 2016-03-23 南加利福尼亚大学 作为糖尿病食疗的禁食条件
MX383483B (es) * 2014-03-06 2025-03-14 Univ Southern California Utilización de régimen de ayuno a corto plazo en combinación con inhibidores de cinasa para potenciar la eficacia y viabilidad de fármacos quimioterápicos tradicionales e invertir los efectos secundarios de cinasas en células y tejidos normales.
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
EP3122354B1 (en) 2014-03-28 2022-06-15 Universita' degli Studi di Genova Tyrosine kinase inhibitors for use in a method of treating cancer in association with a reduced caloric intake
WO2015153850A2 (en) * 2014-04-02 2015-10-08 University Of Southern California Autoimmunity and multiple sclerosis treatment
HK1249858A1 (zh) 2015-04-16 2018-11-16 南加利福尼亚大学 响应於雷帕霉素和地塞米松诱导的标准和高葡萄糖条件禁食模仿膳食(fmd)和降葡萄糖药物保护正常细胞并产生癌症敏感条件
US11000057B2 (en) 2015-05-06 2021-05-11 University Of Southern California Fasting mimicking and enhancing diet for treating hypertension and lipid disorders
CN108601838A (zh) * 2015-09-21 2018-09-28 意大利癌症研究基金会分子肿瘤学研究所(Ifom) 对抗血液癌症的新治疗策略
HK1258621A1 (zh) * 2016-01-12 2019-11-15 南加利福尼亚大学 长期禁食模仿作为多发性骨髓瘤和其他癌症的膳食治疗的用途
BR112018016494A2 (pt) 2016-02-15 2018-12-26 University Of Southern California método para promover regeneração de célula pancreática e reprogramação de célula somática; e pacote de dieta
EP3419615A1 (en) 2016-02-23 2019-01-02 Cancer Research Technology Ltd. Dietary product devoid of at least two non essential amino acids
CN109152790A (zh) 2016-05-11 2019-01-04 南加利福尼亚大学 禁食模仿膳食作为胃肠自身免疫性/炎性疾病的免疫调节治疗剂
IT201700008499A1 (it) 2017-01-26 2018-07-26 Univ Degli Studi Genova Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN107951892A (zh) * 2018-01-19 2018-04-24 丽水学院 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用
BR112020018564A2 (pt) 2018-03-15 2020-12-29 University Of Southern California Composição probiótica para doença gastrointestinal autoimune e/ou inflamatória, uso de uma dieta que simula jejum para prevenir ou tratar doença gastrointestinal autoimune e/ou inflamatória, e suplemento dietário
US20210267250A1 (en) * 2018-07-18 2021-09-02 Andreas Michalsen Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer
JP2022515707A (ja) 2018-11-09 2022-02-22 エル-ニュートラ 断続的断食模倣のための栄養バー
WO2020223522A1 (en) 2019-04-30 2020-11-05 University Of Southern California Fasting-mimicking diet (fmd) as an intervention for alzheimer's disease (ad)
JP6747702B1 (ja) * 2019-05-10 2020-08-26 株式会社医療情報技術研究所 栄養処方管理システム
AU2020276605A1 (en) 2019-05-14 2022-01-20 Tyme, Inc. Compositions and methods for treating cancer
IT201900009954A1 (it) * 2019-06-24 2020-12-24 Fondazione Irccs Istituto Naz Dei Tumori Preparazione alimentare a basso contenuto calorico per l’alimentazione di pazienti affetti da neoplasie
JP7376718B2 (ja) * 2019-12-13 2023-11-08 株式会社ベリタスバイオセラピューティクス 癌の予防または治療用薬学組成物
IT202000007153A1 (it) 2020-04-03 2021-10-03 Ifom Fondazione St Firc Di Oncologia Molecolare Apporto calorico ridotto e immunoterapia per il trattamento del cancro
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections
WO2021247724A1 (en) 2020-06-03 2021-12-09 Faeth Therapeutics, Inc. Formulations for personalized methods of treatment
US12109184B2 (en) 2020-06-04 2024-10-08 Faeth Therapeutics, Inc. Personalized methods of treating cancer
TW202227113A (zh) 2020-12-01 2022-07-16 南加州州立大學 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活
WO2022130420A1 (en) * 2020-12-17 2022-06-23 Fondazione Irccs Istituto Nazionale Dei Tumori Diet preparation for the nutrition of cancer patients with a restricted calorie intake
EP4066823B1 (en) 2021-03-30 2025-04-30 IFOM - Istituto Fondazione di Oncologia Molecolare ETS Reduced caloric intake and anticancer agents for the treatment of cancer
CN115590963A (zh) * 2022-07-13 2023-01-13 复旦大学(Cn) 酮体、酮体诱导剂和生酮组合物中的至少一种在治疗和/或预防血小板减少症药物中的应用
EP4599826A1 (en) 2024-02-06 2025-08-13 IFOM - Istituto Fondazione di Oncologia Molecolare ETS Leucine for use in the treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074731C1 (ru) * 1994-12-29 1997-03-10 Игорь Александрович Бойко Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных
AU749638B2 (en) * 1997-03-17 2002-06-27 Btg International Limited Therapeutic compositions
WO2001006983A2 (en) * 1999-07-22 2001-02-01 Incell Corporation, Llc Fatty acids to minimize cancer therapy side effects
JP4625156B2 (ja) * 2000-04-10 2011-02-02 イーエヌ大塚製薬株式会社 癌化学療法に伴う副作用軽減剤
US20070275934A1 (en) * 2004-05-10 2007-11-29 Curd John G Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
AU2005296271A1 (en) * 2004-10-15 2006-04-27 University Of Tennessee Research Foundation Methods for inducing apoptosis in adipocytes
US20070116802A1 (en) * 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
RU2354369C2 (ru) * 2007-03-16 2009-05-10 Михаил Владимирович Кутушов Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов
WO2008119077A1 (en) * 2007-03-28 2008-10-02 University Of Southern California Induction of differential stress resistance and uses thereof
CN101868235A (zh) * 2007-11-26 2010-10-20 雀巢产品技术援助有限公司 抑制dsRNA-依赖性蛋白激酶激活和抑制肿瘤生长的组合物和方法

Similar Documents

Publication Publication Date Title
JP2013508411A5 (enExample)
Miyata et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer
Frame‐Peterson et al. Nutrient deficiencies are common prior to bariatric surgery
Astrup et al. Overfed but undernourished: recognizing nutritional inadequacies/deficiencies in patients with overweight or obesity
RU2012118588A (ru) Способы и диетологические составы для повышения эффективности и снижения побочных эффектов лечения рака
Arends et al. ESPEN guidelines on enteral nutrition: non-surgical oncology
Richter et al. Parenteral nutrition support for patients with pancreatic cancer–improvement of the nutritional status and the therapeutic outcome
Montégut et al. Science-driven nutritional interventions for the prevention and treatment of cancer
Greenlee Natural products for cancer prevention
US10675262B2 (en) Development of dietary therapy in cancer
Gobato et al. Micronutrient and physiologic parameters before and 6 months after RYGB
Kita et al. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer
RU2734774C2 (ru) Рацион, имитирующий воздержание от пищи (fmd), и лекарственные средства, снижающие уровень глюкозы, защищают нормальные клетки и создают условия сенсибилизации при раке в ответ на стандартные условия и условия с высоким содержанием глюкозы, индуцированные рапамицином и дексаметазоном
US20210145915A1 (en) Formulations for weight loss and methods of use
Baker et al. Nutritional considerations after gastrectomy and esophagectomy for malignancy
Ben-Arye et al. Advising patients on the use of non-herbal nutritional supplements during cancer therapy: a need for doctor-patient communication
Panda et al. Nutritional aspects of healthy aging
Gili et al. The role of prehabilitation in HNSCC patients treated with chemoradiotherapy
Arends et al. Non-surgical oncology–guidelines on parenteral nutrition, chapter 19
Meegaswatte et al. Functional Foods and Nutraceuticals for the Management of Cardiovascular Disease Risk in Postmenopausal Women
Munguti et al. A rare cause of cardiomyopathy: A case of selenium deficiency causing severe cardiomyopathy that improved on supplementation
Bibby et al. Nutritional considerations for the management of the older person with hepato-pancreatico-biliary malignancy
Bıçaklı Individualized nutritional management for cancer patients: a key component of treatment
Moyad Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
Arends Caloric restriction and fasting-mimicking diets in the treatment of cancer patients